HARKNESS TIMOTHY

SVP & Chief Financial Officer at NEKTAR THERAPEUTICS · on record since Aug 24, 2007
Director at SYMYX TECHNOLOGIES INC · on record since Mar 19, 2008
Director at ACCELRYS, INC. · on record since Jul 6, 2010
CFO/VP Finance at MOLECULAR DEVICES CORP · on record since Feb 17, 2005

Insider trading activity of HARKNESS TIMOTHY

Figures computed from official regulatory filings — .

Insufficient history for a statistical track record (fewer than 5 open-market buys).

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
ACCELRYS, INC.	May 1, 2014	Other	-17,844	—	—	SEC
ACCELRYS, INC.	May 1, 2014	Other	-27,071	12.50 USD	$338.4K	SEC
ACCELRYS, INC.	Aug 29, 2013	Sell	-4,864	9.14 USD	$44.5K	SEC
ACCELRYS, INC.	Aug 7, 2013	Sell	-9,000	9.12 USD	$82.1K	SEC
ACCELRYS, INC.	Jun 4, 2013	Award	8,844	—	—	SEC
ACCELRYS, INC.	Aug 27, 2012	Award	9,727	—	—	SEC
ACCELRYS, INC.	Jan 3, 2012	Award	9,000	—	—	SEC
ACCELRYS, INC.	Aug 5, 2010	Award	18,000	—	—	SEC
SYMYX TECHNOLOGIES INC	Jul 6, 2010	Other	-16,929	—	—	SEC
ACCELRYS, INC.	Jul 6, 2010	Award	13,208	—	—	SEC
SYMYX TECHNOLOGIES INC	Jun 15, 2009	Other	8,403	0.00	—	SEC
SYMYX TECHNOLOGIES INC	Jun 18, 2008	Other	6,935	0.00	—	SEC
SYMYX TECHNOLOGIES INC	Mar 19, 2008	Award	1,591	0.00	—	SEC
NEKTAR THERAPEUTICS	Sep 21, 2007	AwardD (derivative)	200,000	8.34	$1.7M	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	ExerciseD (derivative)	-12,500	0.00	—	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Other	-12,500	35.50	$443.8K	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Exercise	12,500	15.85	$198.1K	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Other	-35,000	35.50	$1.2M	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Other	-32,500	35.50	$1.2M	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	ExerciseD (derivative)	-32,500	0.00	—	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	ExerciseD (derivative)	-35,000	0.00	—	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Exercise	32,500	21.32	$692.9K	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Exercise	35,000	19.66	$688.1K	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	ExerciseD (derivative)	-35,000	0.00	—	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Exercise	35,000	29.45	$1M	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
ACCELRYS, INC.	May 1, 2014	Other	-17,844	—	—	SEC
ACCELRYS, INC.	May 1, 2014	Other	-27,071	12.50 USD	$338.4K	SEC
ACCELRYS, INC.	Aug 29, 2013	Sell	-4,864	9.14 USD	$44.5K	SEC
ACCELRYS, INC.	Aug 7, 2013	Sell	-9,000	9.12 USD	$82.1K	SEC
ACCELRYS, INC.	Jun 4, 2013	Award	8,844	—	—	SEC
ACCELRYS, INC.	Aug 27, 2012	Award	9,727	—	—	SEC
ACCELRYS, INC.	Jan 3, 2012	Award	9,000	—	—	SEC
ACCELRYS, INC.	Aug 5, 2010	Award	18,000	—	—	SEC
SYMYX TECHNOLOGIES INC	Jul 6, 2010	Other	-16,929	—	—	SEC
ACCELRYS, INC.	Jul 6, 2010	Award	13,208	—	—	SEC
SYMYX TECHNOLOGIES INC	Jun 15, 2009	Other	8,403	0.00	—	SEC
SYMYX TECHNOLOGIES INC	Jun 18, 2008	Other	6,935	0.00	—	SEC
SYMYX TECHNOLOGIES INC	Mar 19, 2008	Award	1,591	0.00	—	SEC
NEKTAR THERAPEUTICS	Sep 21, 2007	AwardD (derivative)	200,000	8.34	$1.7M	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	ExerciseD (derivative)	-12,500	0.00	—	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Other	-12,500	35.50	$443.8K	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Exercise	12,500	15.85	$198.1K	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Other	-35,000	35.50	$1.2M	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Other	-32,500	35.50	$1.2M	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	ExerciseD (derivative)	-32,500	0.00	—	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	ExerciseD (derivative)	-35,000	0.00	—	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Exercise	32,500	21.32	$692.9K	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Exercise	35,000	19.66	$688.1K	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	ExerciseD (derivative)	-35,000	0.00	—	SEC
MOLECULAR DEVICES CORP	Mar 28, 2007	Exercise	35,000	29.45	$1M	SEC